Michael Celano bought $50K of Larimar Therapeutics stock
By AlphaYouPublished Form 4
Celano Michael
Reporting filer
Michael Celano reported buying 18,460 shares of Larimar Therapeutics, Inc. for about $50K ($2.71 a share on average). Form 4 filed Nov 12, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Celano Michael | 2026-11-11 | P | Purchase | 18460 | 2.7081 | 234,245 | 1 day | Filed terms
|
Common Stock
- Owner
- Celano Michael
- Date
- 2026-11-11
- Code
- P
- Action
- Purchase
- Quantity
- 18460
- Price
- 2.7081
- Following holdings
- 234,245
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 18460
- transaction Price Per Share: 2.7081
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 234245
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Celano Michael: Chief Financial Officer.
- F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.695 to $2.715, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Original sources
Prepared automatically from public filing data. Report a correction.